MEG3 and hepatocellular carcinoma: For instance, miRNA-29 upregulates the expression of lncRNA MEG3 through the inhibition of DNA methyltransferase activity, resulting in a reduction of methylation of MEG3 promoter in hepatocellular cancer [121].